comparing cardiovascular and kidney outcomes with tirzepatide vs. glp-1 agonists Renal effects of receptor in individuals type 2 diabetes: seeds of a promising future | Endocrine Beyond glycemia: Comparing tirzepatide to

Treatment potential of the GLP-1 receptor agonists in type 2 diabetes mellitus: a review

The Victims of GLP-1 Drugs Across Industries Figure 2, Average Weight Loss Across Treatments (%) Diabesity-Related Surgical & Medical Devices Sleep Apnea Obstructive sleep apnea (OSA) is a common problem among obese patients (around 40% of obese patients suffer from OSA), while around 70% of OSA patients are obese [15]

If your doctor does not ask about these, bring them up yourself

2020 (6) CD012906

There are no approved generic versions of Wegovy, despite what you may see advertised

The anti-inflammatory and antioxidant effects of GLP-1RAs observed in other organ systems may prevent damage in ocular tissues, leading to reduced risk of nonexudative age-related macular degeneration (AMD), exudative AMD, and primary open-angle glaucoma (POAG) compared to other diabetic medications (Figure 1)